Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €74.60 EUR
Change Today -1.91 / -2.49%
Volume 92.7K
As of 3:35 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

wacker chemie ag (WCH) Snapshot

Open
€75.80
Previous Close
€76.50
Day High
€76.58
Day Low
€73.95
52 Week High
03/11/15 - €117.83
52 Week Low
08/24/15 - €73.01
Market Cap
3.9B
Average Volume 10 Days
150.2K
EPS TTM
€5.74
Shares Outstanding
52.2M
EX-Date
05/11/15
P/E TM
13.0x
Dividend
€1.50
Dividend Yield
2.01%
Current Stock Chart for WACKER CHEMIE AG (WCH)

Related News

No related news articles were found.

wacker chemie ag (WCH) Related Businessweek News

No Related Businessweek News Found

wacker chemie ag (WCH) Details

Wacker Chemie AG offers specialty chemical products worldwide. Its Wacker Silicones division offers approximately 3,000 silicone products, including silanes, silicone fluids, emulsions, elastomers, sealants, resins, and pyrogenic silicas. This division’s products are used in construction, paints and coating, chemical, cosmetic, textile and leather, paper and film coating, fabric coating, electrical and electronic engineering, insulation technology, mechanical engineering and metal processing, medical technology, automotive, communication technology, office equipment and household appliance, plastic and rubber processing, and mold making industries. The company’s Wacker Polymers division provides polymeric binders and polymeric additives, such as dispersible polymer powders and dispersions, surface-coating resins, polyvinyl alcohol solutions, and polymer modifiers. This division’s products are used in applications, such as automotive, construction chemicals, adhesives, paints and coatings, nonwovens, textiles, and papers. Its Wacker Biosolutions division offers bioengineered products, including cyclodextrins, cyclodextrin complexes, cysteine, and cysteine; biopharmaceuticals; fine chemicals; organosilanes; chiral alcohols; base chemicals; and polyvinyl acetate solid resins under the CAVASOL and CAVAMAX trademarks. This division’s products applications include foodstuffs, pharmaceuticals and biologics, agrochemicals, specialty chemicals, and chemical industries, as well as household, personal care, and cosmetic products. The company’s Wacker Polysilicon division produces polysilicon for the semiconductor electronics and solar cells. Its Siltronic division offers silicon wafers used as raw material for various semiconductor products for discrete semiconductor components or microchips. The company was founded in 1914 and is headquartered in Munich, Germany. Wacker Chemie AG is a subsidiary of Dr. Alexander Wacker Familiengesellschaft mbH.

16,928 Employees
Last Reported Date: 08/4/15
Founded in 1914

wacker chemie ag (WCH) Top Compensated Officers

Chief Executive Officer, President and Member...
Total Annual Compensation: €1.0M
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €572.5K
Member of Executive Board
Total Annual Compensation: €572.5K
Member of the Executive Board
Total Annual Compensation: €400.0K
Compensation as of Fiscal Year 2014.

wacker chemie ag (WCH) Key Developments

WACKER BIOSOLUTIONS Reports Earnings Results for the Second Quarter Ended June 30, 2015; Provides Earnings Guidance for the Full Year of 2015

WACKER BIOSOLUTIONS reported earnings results for the second quarter ended June 30, 2015. For the quarter, the company generated total sales of EUR 52.7 million against EUR 46.6 million a year ago, 13% more than a year ago. Favorable exchange rates and higher prices were the main drivers of this growth. The company also further enhanced its EBITDA which at EUR 9.5 million was up by about 16% over second quarter of 2014 of EUR 8.2 million. Higher sales were the main factor driving this growth. The company expects to post substantial growth in 2015. Now that Scil Proteins Production GmbH in Halle (Germany) has been integrated, the division sees further growth potential for its biologics business. EBITDA should also show a clear year-over-year increase.

Wacker Chemie AG Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Full Year of 2015

Wacker Chemie AG reported consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported sales of EUR 1,370.5 million against EUR 1,242.3 million a year ago. EBITDA was EUR 329 million against EUR 229.5 million a year ago. EBIT was EUR 187.9 million against EUR 82.1 million a year ago. Income before taxes was EUR 168 million against EUR 59.1 million a year ago. Net income for the period was EUR 108.2 million against EUR 29.4 million a year ago. Earnings per share were EUR 2.21 against EUR 0.64 per share a year ago. Capital expenditures were EUR 214.2 million against EUR 101 million a year ago. Net cash flow was EUR 21 million against EUR 49.6 million a year ago. The main reason for this substantial year-over-year decline was higher capital expenditure than in second quarter of 2014. For the six months, the company reported sales of EUR 2,705.4 million against EUR 2,399.7 million a year ago. EBITDA was EUR 596.1 million against EUR 514.7 million a year ago. EBIT was EUR 314.2 million against EUR 215.9 million a year ago. Income before taxes was EUR 287.3 million against EUR 169.2 million a year ago. Net income for the period was EUR 178.8 million against EUR 93.6 million a year ago. Earnings per share were EUR 3.63 against EUR 1.99 per share a year ago. Capital expenditures were EUR 389.1 million against EUR 190.3 million a year ago. Net cash flow was EUR 38.4 million against EUR 154.1 million a year ago. Net financial debt as at June 30, 2015 was EUR 938.9 million against EUR 920.9 million a year ago. The company expects its full-year 2015 sales to rise by about 10%. The company anticipates a moderate year-over-year rise in EBITDA on a comparable basis, i.e. adjusted to exclude special income. The return on capital employed (ROCE) is expected to be slightly lower than last year's figure of 8.4%. At about EUR 775 million, capital expenditures will be higher than last year. Depreciation will amount to around EUR 625 million, slightly higher than last year's figure. Net cash flow will be slightly positive. Net financial debt at year-end is expected to remain roughly at the prior-year level. Group net income is projected to be lower than last year. For the full year, the company expects the tax rate of slightly - above 50% as nondeductible expenses for the ramp in Tennessee increase during - through the year and with lower special effects in the second half. With a slightly positive net cash flow, the company now expect net year-end financial debt at the level of 2014, so that it's just over EUR 1 billion. The company believes that it can reach EUR 1 billion in reported EBITDA for 2015.

Wacker SILICONES Reports Earnings Results for the Second Quarter Ended June 30, 2015; Provides Earnings Guidance for the Full Year of 2015

Wacker SILICONES reported earnings results for the second quarter ended June 30, 2015. For the quarter, the company reported that it has increased its sales and earnings. Between April and June 2015, the division generated total sales of EUR 506.3 million against EUR 441.2 million a year ago. Relative to a year ago, sales were up almost 15%. Favorable exchange rates and higher volumes were the main factors driving sales. Somewhat improved prices in certain product segments also lifted sales year over year. Higher sales were the main reason that the company posted a substantial increase in EBITDA. EBITDA reached EUR 77.3 million against EUR 57.4 million a year ago, almost 35% more than a year ago. Sales at WACKER SILICONES are expected to increase substantially in 2015. Particular areas of growth are products and applications for personal care and medical technology, as well as for the electrical and electronics sectors. EBITDA is expected to be markedly above the prior-year figure. However, higher prices for silicon-metal will dampen that increase somewhat.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WCH:GR €74.60 EUR -1.91

WCH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €60.55 EUR -1.93
Ashland Inc $100.82 USD -1.67
Clariant AG SFr.17.52 CHF -0.30
GCL-Poly Energy Holdings Ltd $1.18 HKD -0.04
Valspar Corp/The $72.82 USD -0.94
View Industry Companies
 

Industry Analysis

WCH

Industry Average

Valuation WCH Industry Range
Price/Earnings 13.2x
Price/Sales 0.7x
Price/Book 1.5x
Price/Cash Flow 13.8x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WACKER CHEMIE AG, please visit www.wacker.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.